Founded in 2018, Resinno Biotech operates in Health Tech offering innovative and high-quality pharmaceutical and biotech products. The company is driven by a team of researchers and professionals comm...
Company Type:
Bootstrapped
Revenue:
₹1.6 Cr+ (FY25)
₹1.6 Cr+ (FY25)
Employee count:
23
Last 90d
23
Last 90d
Web traffic:
930
930
Last 30d
Last 30d
Resinno Biotech: Cap Table Highlights
A snapshot of cap table and shareholder metrics
Total Shareholders29
Latest Filing Date30 March 2024- Funding Events18
Event-Based View
Event-Based detailed View by Filings
FAQs on Cap Table of Resinno Biotech
As of 31 March 2024, Resinno Biotech's equity is held by 29 shareholders, with the top three being Kafil Ahmed, Rasshad Mohammad Khan, and Abdulhadi Abdulqafi Nomani.
Kafil Ahmed holds the largest stake in Resinno Biotech at 25.9% as of 31 March 2024.
As of 31 March 2024, founders collectively hold 25.9% equity in Resinno Biotech.
As of 31 March 2024, investors collectively hold 74.1% equity in Resinno Biotech.
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links